Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound (TcMRgFUS) of Neurological Disorders:

NCT03100474 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT03100474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03100474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound (TcMRgFUS) of Neurological Disorders:
Lead sponsor
InSightec
Phase
Observational
Overall status
Active, not recruiting
Start date
December 31, 2016
Completion date
June 30, 2026
Enrollment
500 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

essential tremor, movement disorders, neuropathic pain, parkinson's disease